1 Department of Radiology, University of Michigan Health System, 1500 E Medical Center Dr, B2-A209P, Ann Arbor, MI 48109-5030.
AJR Am J Roentgenol. 2014 Apr;202(4):784-9. doi: 10.2214/AJR.13.11369.
The objective of our study was to exposit the shifting perspectives on contrast-induced nephropathy (CIN) for IV low-osmolar iodinated contrast media.
The historically inflated risk of CIN reflects logistic and intellectual pitfalls that continue to confound the study of this disease. Recent advances have clarified that the incidence of CIN is much lower than previously thought, but there are lingering questions. We suggest that CIN is likely real but is rare and offer directions for future study.
本研究旨在阐述人们对静脉注射低渗型碘造影剂引起的对比剂肾病（CIN）的看法的转变。
过去 CIN 的风险被高估，这反映出在研究这种疾病时存在逻辑和认知上的缺陷。最近的研究进展表明，CIN 的发生率远低于之前的预期，但仍存在一些悬而未决的问题。我们认为 CIN 很可能确实存在，但比较罕见，并为未来的研究提供了方向。
